Silvia Coco
Monza, 20900, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 28, 2024
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein.
Journal: International journal of molecular sciences
Published: September 27, 2022
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis.
Journal: Current neuropharmacology
Published: June 01, 2022
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury.
Journal: Drug target insights
Published: September 24, 2021
Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 07, 2021
Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects.
Journal: International journal of molecular sciences
Published: March 01, 2021
TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling.
Journal: International journal of molecular sciences
Published: December 02, 2019
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease.
Journal: Stem cells translational medicine
Published: September 28, 2019
Growth Hormone Secretagogues and the Regulation of Calcium Signaling in Muscle.
Journal: International journal of molecular sciences
Published: August 01, 2019
Last Updated: 09/26/2026